Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imad M Tleyjeh

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)Imad M Tleyjeh
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 23, 2023
Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteriaImad M Tleyjeh
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 11, 2021
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's replyTarek Kashour, Imad M Tleyjeh
Medical Hypotheses|December 1, 2020
It is time to drop hydroxychloroquine from our COVID-19 armamentariumTarek Kashour, Imad M Tleyjeh
Saudi Medical Journal|October 30, 2007
Tuberculosis paradoxical reactionFayaz Hakim, Imad M Tleyjeh
Journal of General Internal Medicine|January 12, 2021
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York CityImad M Tleyjeh, Tarek Kashour
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2013
Early cardiac surgery after ischemic stroke in patients with infective endocarditis may not be safeImad M Tleyjeh, Larry M Baddour
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
The potential impact of survivor treatment selection bias on the perceived efficacy of valve surgery in the treatment of infective endocarditisImad M Tleyjeh, Larry M Baddour
Current Infectious Disease Reports|July 11, 2006
Changing epidemiology of infective endocarditisImad M Tleyjeh, James M Steckelberg
Mayo Clinic Proceedings|October 3, 2007
Staphylococcus aureus bacteremia and infective endocarditis: old questions, new answers?Imad M Tleyjeh, Larry M Baddour
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)Imad M Tleyjeh
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 23, 2023
Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteriaImad M Tleyjeh
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 11, 2021
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's replyTarek Kashour, Imad M Tleyjeh
Medical Hypotheses|December 1, 2020
It is time to drop hydroxychloroquine from our COVID-19 armamentariumTarek Kashour, Imad M Tleyjeh
Saudi Medical Journal|October 30, 2007
Tuberculosis paradoxical reactionFayaz Hakim, Imad M Tleyjeh
Journal of General Internal Medicine|January 12, 2021
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York CityImad M Tleyjeh, Tarek Kashour
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2013
Early cardiac surgery after ischemic stroke in patients with infective endocarditis may not be safeImad M Tleyjeh, Larry M Baddour
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
The potential impact of survivor treatment selection bias on the perceived efficacy of valve surgery in the treatment of infective endocarditisImad M Tleyjeh, Larry M Baddour
Current Infectious Disease Reports|July 11, 2006
Changing epidemiology of infective endocarditisImad M Tleyjeh, James M Steckelberg
Mayo Clinic Proceedings|October 3, 2007
Staphylococcus aureus bacteremia and infective endocarditis: old questions, new answers?Imad M Tleyjeh, Larry M Baddour
Pageof 11